Document is current
Any future updates will be listed below
-
Authors
Rossi, Cecilia https://orcid.org/0009-0001-4422-4036
Bumbasirevic, Marko
Čvančara, Paul https://orcid.org/0000-0003-2189-4413
Stieglitz, Thomas https://orcid.org/0000-0002-7349-4254
Raspopovic, Stanisa https://orcid.org/0000-0003-0567-9051
Donati, Elisa https://orcid.org/0000-0002-8091-1298
Valle, Giacomo https://orcid.org/0000-0002-2637-8007
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (759998)
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 25 January 2026
First Online: 8 February 2026
Competing interests
: G.V. holds shares of “MYNERVA AG”, a start-up company dealing with the potential commercialization of noninvasive stimulating wearable for treating neuropathic pain. G.V. serves as a consultant for NeuroOne Medical Technologies Corporation (USA). The other authors do not have anything to disclose.
